Alporo, Feleciano M.
HRN: 25-17-20 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/30/2024
06/06/2024
IV
4.5g
Q6
CMBO
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes